Successful treatment of oxidative stress in vitiligo

Skin Pharmacology and Applied Skin Physiology

Volumn 12, Issue 3, 1999, Pages 132-138

  Schallreuter, K U ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

Author keywords

Calcium; Hydrogen peroxide; Pseudocatalase; UVB; Vitiligo

Indexed keywords

CALCIUM; CATALASE; HYDROGEN PEROXIDE;

CONFERENCE PAPER; EPIDERMIS; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SKIN PIGMENTATION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET B RADIATION; VITILIGO;

CALCIUM; CATALASE; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HOMEOSTASIS; HUMANS; HYDROGEN PEROXIDE; MALE; OXIDATIVE STRESS; PTERIDINES; SKIN; ULTRAVIOLET RAYS; VITILIGO;

EID: 0032968531     PISSN: 14222868     EISSN: None     Source Type: Journal    
DOI: 10.1159/000029867     Document Type: Conference Paper

References (28)

1. Ortonne JP, Bose SK: Vitiligo: Where do we stand? Pigment Cell Res 1993;8:61-72.
2. Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF (eds): Fitzpatrick's Dermatology in General Medicine, ed 4. New York, McGraw-Hill, 1993.
3. Schallreuter KU, Wood JM, Pittelkow MR, Gütlich M, Lemke KR, Rödl W, Swanson NN, Hitzemann K, Ziegler I: Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994;263:1444-1446.
4. Hopkins FG: Note on a yellow pigment in butterflies. Proc Chem Soc 1889;5:117; Nature 1889;40:335.
5. Hopkins FG: Note on a yellow pigment in butterflies. Proc Chem Soc 1889;5:117; Nature 1889;40:335.
6. Ziegler I: Production of pteridines during hematopoiesis and T-lymphocyte proliferation: Potential participation in the control of cytokine signal transmission. Med Res Rev 1990;10:95-114.
7. Davis MD, Ribeiro P, Tipper J, Kaufman S: '7-Tetrahydrobiopterin', a naturally occurring analogue of tetrahydrobiopterin, is a cofactor for and a potential inhibitor of the aromatic amino acid hydrolases. Proc Natl Acad Sci USA 1992;89:10108-10113.
8. Schallreuter KU, Zschiesche M, Moore J, Panske A, Hibberts NA, Herrmann FH, Metelmann HR, Sawatzki J: In vivo evidence for compromised phenylalanine metabolism in vitiligo. Biochem Biophys Res Commun 1998;243:395-399.
9. Prota G: Melanins and Melanogenesis. New York, Academic Press, 1976.
10. Naoi M, Parvez SH: Tyrosine Hydroxylase. Utrecht, VSP, 1993.
11. Wood JM, Schallreuter-Wood KU, Lindsey NJ, Callaghan S, Gardner MLG: A specific tetrahydrobiopterin binding domain on tyrosinase controls melanogenesis. Biochem Biophys Res Commun 1995;206: 480-485.
12. Gokhale BB, Mehta LH: Histopathology of vitiliginous skin. Int J Dermatol 1983;22:447.
13. Le Poole IC, van den Wijngaard RM, Westerhof W, Dutrieux RP, Das PK: Presence or absence of melanocytes in vitiligo lesions: An immunohistochemical investigation. J Invest Dermatol 1993;100:816-822.
14. Moellman G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner A: Extracellular granular material and degeneration of keratinocytes in normally pigmented epidermis of patients with vitiligo. J Invest Dermatol 1982;79:321-330.
15. Bhawan J, Bhutani LK: Keratinocyte damage in vitiligo. J Cutan Pathol 1983;10:207-212.
16. Boissy R, Liu YY, Medrano EE, Nordlund JJ: Structural aberration of the rough endoplasmic reticulum and melanosome compartmentalisation in long term cultures of melanocytes from vitiligo patients. J Invest Dermatol 1991;97:395-404.
17. Yohn JJ, Norris DA, Yrastorza G, Bruno IS, Leff JA, Hake SS, Repine JE: Disparate antioxidant enzyme activities in cultured human cutaneous fibroblasts, keratinocytes and melanocytes. J Invest Dermatol 1991;97:405-409.
18. Schallreuter KU, Wood JM, Berger J: Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol 1991;97:1081-1085.
19. Maresca V, Roccella M, Roccella F, Camera E, Del Porto G, Passi S, Grammatico P, Picardo M: Increased sensitivity to peroxidative agents as a possible pathogenic factor of melanocyte damage in vitiligo. J Invest Dermatol 1997;109:310-313.
20. Aronoff S: Catalase: Kinetics of photo-oxidation. Science 1965;150:72-73.
21. Schallreuter KU, Wood JM, Pittelkow MR, Büttner G, Swanson NN, Körner C, Ehrke C: Increased monoamine oxidase A activity in the epidermis of patients with vitiligo. Arch Dermatol Res 1996;288: 14-18.
22. Marks DB, Marks AD, Smith CM: Oxygen metabolism and oxygen toxicity; in Basic Medical Biochemistry: A Clinical Approach. Baltimore, Williams and Wilkins, 1996, pp 327-340.
23. Schallreuter KU, Wood JM: EF-hands calcium binding regulates the thioredoxin reductase/thioredoxin electron transfer in human keratinocytes and melanoma; in Heizmann CW (ed): Novel Calcium-Binding Proteins. Berlin, Springer, 1991, pp 339-360.
24. Schallreuter KU, Pittelkow MR: Defective calcium uptake in keratinocyte cell cultures from vitiliginous skin. Arch Dermatol Res 1988;280: 137-139.
25. Schallreuter-Wood KU, Pittelkow MR, Swanson NN: Defective calcium transport in vitiliginous melanocytes. Arch Dermatol Res 1996; 288:11-13.
26. Schallreuter KU, Wood JM, Lemke KR, Levening C: Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: A case study on 33 patients. Dermatology 1995;190:223-229.
27. Westerhof W, Nieuweboer-Krobotova L: Treatment of vitiligo with UVB radiation vs topical psoralen plus UVA. Arch Dermatol 1997; 133:1525-15528.
28. Schallreuter KU: Beta adrenergic blocking agents can provoke vitiligo. Br J Dermatol 1995;132:168-169.